DrugPatentWatch Database Preview
Aminophylline - Generic Drug Details
» See Plans and Pricing
What are the generic sources for aminophylline and what is the scope of freedom to operate?
Aminophylline
is the generic ingredient in nine branded drugs marketed by Fisons, Gd Searle Llc, Abraxis Pharm, Am Regent, Elkins Sinn, Hospira, Intl Medication, King Pharms, Luitpold, Lyphomed, Pharma Serve Ny, Smith And Nephew, Teva Parenteral, Morton Grove, Roxane, Actavis Mid Atlantic, Cosette, Impax Labs, Tablicaps, Vale, Pharm Res Assoc, Ani Pharms Inc, Ascot, Barr, Duramed Pharms Barr, Halsey, Hikma Intl Pharms, Kv Pharm, Lannett, Pal Pak, Panray, Purepac Pharm, Valeant Pharm Intl, Vangard, Vintage Pharms, and Watson Labs, and is included in sixty-six NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for aminophylline. Four suppliers are listed for this compound.
Summary for aminophylline
| US Patents: | 0 |
| Tradenames: | 9 |
| Applicants: | 36 |
| NDAs: | 66 |
| Drug Master File Entries: | 4 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 62 |
| Clinical Trials: | 26 |
| Patent Applications: | 6,954 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in aminophylline? | aminophylline excipients list |
| DailyMed Link: | aminophylline at DailyMed |
Recent Clinical Trials for aminophylline
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Beni-Suef University | Phase 1 |
| Wuhan Union Hospital, China | Phase 4 |
| Le Bonheur Children's Hospital | Phase 3 |
Pharmacology for aminophylline
| Drug Class | Methylxanthine |
Medical Subject Heading (MeSH) Categories for aminophylline
US Patents and Regulatory Information for aminophylline
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ascot | AMINOPHYLLINE | aminophylline | TABLET;ORAL | 087522-001 | Feb 12, 1982 | DISCN | No | No | Get Started for $10 | Get Started for $10 | Get Started for $10 | ||||
| Vintage Pharms | AMINOPHYLLINE | aminophylline | TABLET;ORAL | 085410-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Get Started for $10 | Get Started for $10 | Get Started for $10 | ||||
| Duramed Pharms Barr | AMINOPHYLLINE | aminophylline | TABLET;ORAL | 088182-001 | Mar 31, 1983 | DISCN | No | No | Get Started for $10 | Get Started for $10 | Get Started for $10 | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2021 - 2022
NCE-1 Patent Challenge Dates 2021 - 2022
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
